V. Mikol
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment
Papers in
-
- Signaling Pathways in Disease 5
- Protein Structure and Dynamics 2
-
- Toxin Mechanisms and Immunotoxins 3
- Immunodeficiency and Autoimmune Disorders 2
- Co-authors
- Richard Giegé (3 shared papers)Ernest Hirsch (2 shared papers)J.P. Guilloteau (2 shared papers)Qing Zhou-Liu (1 shared paper)S. Maignan (1 shared paper)Malcolm D. Walkinshaw (4 shared papers)Jörg Kallen (1 shared paper)Magali Mathieu (1 shared paper)
- Journals
- Journal of Molecular Biology (5 papers)Journal of Applied Crystallography (2 papers)British Journal of Dermatology (1 paper)Protein Engineering Design and Selection (1 paper)FEBS Letters (1 paper)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
V. Mikol
19 papers receiving 717 citations
Peers
Comparison fields: 5 of 83
- Virology 167
- Infectious Diseases 187
- Molecular Biology 507
- Pharmacology 91
- Toxicology 14
Countries citing papers authored by V. Mikol
This map shows the geographic impact of V. Mikol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Mikol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Mikol more than expected).
Fields of papers citing papers by V. Mikol
This network shows the impact of papers produced by V. Mikol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Mikol. The network helps show where V. Mikol may publish in the future.
Co-authors
The 25 scholars most cited alongside V. Mikol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 236 | |
| 2 | 2009 | 128 | |
| 3 | 1990 | 110 | |
| 4 | 1994 | 81 | |
| 5 | 1988 | 44 | |
| 6 | 1989 | 34 | |
| 7 | 1989 | 30 | |
| 8 | 1998 | 12 | |
| 9 | 1994 | 12 | |
| 10 | Anti-lipopolysaccharide core antibodies. | 1994 | 10 |
| 11 | 1996 | 8 | |
| 12 | 1996 | 7 | |
| 13 | 2004 | 7 | |
| 14 | 2025 | 6 | |
| 15 | 1991 | 6 | |
| 16 | 2025 | 2 | |
| 17 | 1994 | 1 | |
| 18 | 2025 | 1 | |
| 19 | 2025 | 1 |
About V. Mikol
V. Mikol is a scholar working on Molecular Biology, Immunology, Materials Chemistry, Organic Chemistry and Genetics, having authored 19 papers that have together received 736 indexed citations. Recurring topics across this work include Signaling Pathways in Disease (5 papers), Enzyme Structure and Function (4 papers), Toxin Mechanisms and Immunotoxins (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Protein Structure and Dynamics (2 papers), Crystallization and Solubility Studies (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Virology (167 citations), Infectious Diseases (187 citations), Molecular Biology (507 citations), Pharmacology (91 citations) and Toxicology (14 citations). V. Mikol has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Richard Giegé, Ernest Hirsch, J.P. Guilloteau, Qing Zhou-Liu, S. Maignan, Malcolm D. Walkinshaw, Jörg Kallen, Magali Mathieu, Jean‐Luc Rodeau and Nadine Michot. Their work appears in journals such as Journal of Molecular Biology, Journal of Applied Crystallography, British Journal of Dermatology, Protein Engineering Design and Selection and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.